Oxidation of low density lipoprotein in patients on regular haemodialysis.
Patients undergoing chronic haemodialysis are known to have a high incidence of premature atherosclerosis for reasons which have not been fully elucidated. The susceptibility of low density lipoprotein (LDL) to oxidation by copper ions in vitro is widely used as a measure of its atherogenicity in vivo. We measured the susceptibility of LDL to oxidation using copper ions in haemodialysis patients and found, surprisingly, a markedly increased resistance to oxidation. The experiment was therefore repeated using an alternative free radical generator, AAPH [2,2'-azobis-(2-amidinopropane hydrochloride)], to promote LDL oxidation; using AAPH, the susceptibility to oxidation was similar in the dialysis group compared to controls. Abnormal LDL composition in the dialysis patients was also demonstrated. We suggest that, in such situations, susceptibility of LDL to oxidation in vitro may be highly dependent on the biochemical method employed and therefore may not accurately reflect atherogenic risk.
Department of Clinical Biochemistry, Queen's University, Belfast, UK.
C M
CM
Loughrey
I S
IS
Young
J
J
McEneny
I F
IF
McDowell
C
C
McMaster
P T
PT
McNamee
E R
ER
Trimble
D000578:Amidines; D001161:Arteriosclerosis / Q000378:metabolism; D003300:Copper; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000378:metabolism*; D010084:Oxidation-Reduction; D006435:Renal Dialysis; D014810:Vitamin E / Q000032:analysis
D000578:Amidines; D008055:Lipids; D008077:Lipoproteins, LDL; D014810:Vitamin E; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; C028419:cuprous chloride